814 related articles for article (PubMed ID: 16881107)
21. Does renal function influence plasma levels of advanced glycation and oxidation protein products in patients with chronic rheumatic diseases complicated by secondary amyloidosis?
Rysavá R; Kalousová M; Zima T; Dostál C; Merta M; Tesar V
Kidney Blood Press Res; 2007; 30(1):1-7. PubMed ID: 17191033
[TBL] [Abstract][Full Text] [Related]
22. Significant association between renal function and area of amyloid deposition in kidney biopsy specimens in both AA amyloidosis associated with rheumatoid arthritis and AL amyloidosis.
Kuroda T; Tanabe N; Hasegawa E; Wakamatsu A; Nozawa Y; Sato H; Nakatsue T; Wada Y; Ito Y; Imai N; Ueno M; Nakano M; Narita I
Amyloid; 2017 Jun; 24(2):123-130. PubMed ID: 28613962
[TBL] [Abstract][Full Text] [Related]
23. Renal amyloidosis followed more than 5 years: report of 12 cases.
Kaaroud H; Boubaker K; Béji S; Abderrahim E; Moussa FB; Turki S; Goucha R; Hedri H; El Younsi F; Kheder A; Maiz HB
Transplant Proc; 2004; 36(6):1796-8. PubMed ID: 15350480
[TBL] [Abstract][Full Text] [Related]
24. [AA-amyloidosis in inflammatory rheumatic diseases. A report of clinical experiences].
Schneider F
Z Rheumatol; 1992; 51(4):177-82. PubMed ID: 1414042
[TBL] [Abstract][Full Text] [Related]
25. [Secondary amyloidosis (AA) and renal disease].
Torregrosa E; Hernández-Jaras J; Calvo C; Ríus A; García-Pérez H; Maduell F; Vera JM
Nefrologia; 2003; 23(4):321-6. PubMed ID: 14558331
[TBL] [Abstract][Full Text] [Related]
26. Fatal pancreatitis associated with systemic amyloidosis in a rheumatoid arthritis patient.
Oishi K; Wada J; Nagake Y; Hida K; Hashimoto H; Hayakawa N; Kashihara N; Makino H
J Med; 2000; 31(5-6):303-10. PubMed ID: 11508323
[TBL] [Abstract][Full Text] [Related]
27. [Secondary (AA) renal/bone amyloidosis complicating rheumatoid arthritis].
Prkacin I; Skurla B; Pocanić D; Bulum T; Bulimbasić S; Kardum-Skelin I
Acta Med Croatica; 2011 Sep; 65 Suppl 1():217-21. PubMed ID: 23126056
[TBL] [Abstract][Full Text] [Related]
28. [Systemic AA amyloidosis induced by benign neoplasms].
Bestard Matamoros O; Poveda Monje R; Ibernon Vilaró M; Carrera Plans M; Grinyó Boira JM
Nefrologia; 2008; 28(1):93-8. PubMed ID: 18336138
[TBL] [Abstract][Full Text] [Related]
29. Renal function at the time of renal biopsy as a predictor of prognosis in patients with primary AL-type amyloidosis.
Osawa Y; Kawamura K; Kondo D; Imai N; Ueno M; Nishi S; Iino N; Okada M; Suzuki Y; Hoshino S; Yamazaki H; Kishimoto H; Shimada H; Yamagishi T; Ishiyama T; Narita I; Gejyo F
Clin Exp Nephrol; 2004 Jun; 8(2):127-33. PubMed ID: 15235929
[TBL] [Abstract][Full Text] [Related]
30. [Secondary amyloidosis in rheumatoid arthritis. A clinical study of 29 patients].
Fiter Aresté J; Nolla Solé JM; Gómez Vaquero C; Valverde García J; Roig Escofet D
An Med Interna; 1999 Dec; 16(12):615-9. PubMed ID: 10686712
[TBL] [Abstract][Full Text] [Related]
31. The clinical significance of amyloid fat deposits in rheumatoid arthritis: a systematic long-term followup study using abdominal fat aspiration.
Gómez-Casanovas E; Sanmartí R; Solé M; Cañete JD; Muñoz-Gómez J
Arthritis Rheum; 2001 Jan; 44(1):66-72. PubMed ID: 11212178
[TBL] [Abstract][Full Text] [Related]
32. [A study of rheumatoid arthritis patients associated with biopsy-proven secondary amyloidosis].
Nakano M; Yamada T; Ozawa T; Kikuchi M; Satoh T; Nakazono K; Hanyu T; Murasawa A; Arakawa M
Ryumachi; 1989 Aug; 29(4):251-8. PubMed ID: 2617367
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of etanercept vs cyclophosphamide as treatment for patients with amyloid A amyloidosis secondary to rheumatoid arthritis.
Nakamura T; Higashi S; Tomoda K; Tsukano M; Shono M
Rheumatology (Oxford); 2012 Nov; 51(11):2064-9. PubMed ID: 22879465
[TBL] [Abstract][Full Text] [Related]
34. Renal involvement in systemic amyloidosis.
Browning M; Banks R; Tribe C; Bacon P; Hollingworth P; Kingswood C; Poulding J; Harrison P; Mackenzie JC
Proc Eur Dial Transplant Assoc; 1983; 20():595-602. PubMed ID: 6657678
[TBL] [Abstract][Full Text] [Related]
35. [Kidney involvement in patients with rheumatoid arthritis].
Krel' OV; Varshavskiĭ VA; Kanevskaia MZ; Khamishon LZ; Chichasova NV; Krel' AA
Ter Arkh; 1990; 62(6):104-13. PubMed ID: 2218905
[TBL] [Abstract][Full Text] [Related]
36. [Lethal complications and associated diseases of rheumatoid arthritis--a retrospective clinicopathologic study of 234 autopsy patients].
Bély M; Apáthy A
Orv Hetil; 2006 Jun; 147(23):1063-76. PubMed ID: 16856508
[TBL] [Abstract][Full Text] [Related]
37. Prevalence and origin of amyloid in kidney biopsies.
von Hutten H; Mihatsch M; Lobeck H; Rudolph B; Eriksson M; Röcken C
Am J Surg Pathol; 2009 Aug; 33(8):1198-205. PubMed ID: 19561448
[TBL] [Abstract][Full Text] [Related]
38. Treatment of renal amyloidosis with dimethylsulphoxide (DMSO).
van Rijswijk MH; Donker AJ; Ruinen L; Marrink J
Proc Eur Dial Transplant Assoc; 1979; 16():500-5. PubMed ID: 548994
[TBL] [Abstract][Full Text] [Related]
39. Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidney.
Gertz MA; Leung N; Lacy MQ; Dispenzieri A; Zeldenrust SR; Hayman SR; Buadi FK; Dingli D; Greipp PR; Kumar SK; Lust JA; Rajkumar SV; Russell SJ; Witzig TE
Nephrol Dial Transplant; 2009 Oct; 24(10):3132-7. PubMed ID: 19403931
[TBL] [Abstract][Full Text] [Related]
40. [AA amyloidosis: a little-known complication of chronic leg ulcer].
Waton J; Fays-Michel S; Chandeclerc ML; Corby S; Cuny JF; Barbaud A; Schmutz JL
Ann Dermatol Venereol; 2008 Feb; 135(2):119-22. PubMed ID: 18342093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
